BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 31302142)

  • 1. Development and Validation of a Model Consisting of Comorbidity Burden to Calculate Risk of Death Within 6 Months for Patients With Suspected Drug-Induced Liver Injury.
    Ghabril M; Gu J; Yoder L; Corbito L; Ringel A; Beyer CD; Vuppalanchi R; Barnhart H; Hayashi PH; Chalasani N
    Gastroenterology; 2019 Nov; 157(5):1245-1252.e3. PubMed ID: 31302142
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Significant Medical Comorbidities Are Associated With Lower Causality Scores in Patients Presenting With Suspected Drug-Induced Liver Injury.
    Ghabril M; Gu J; Yoder L; Corbito L; Dakhoul L; Ringel A; Beyer CD; Vuppalanchi R; Barnhart H; Hayashi PH; Chalasani N
    Clin Transl Gastroenterol; 2020 Apr; 11(4):e00141. PubMed ID: 32251016
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Features and Outcomes of 899 Patients With Drug-Induced Liver Injury: The DILIN Prospective Study.
    Chalasani N; Bonkovsky HL; Fontana R; Lee W; Stolz A; Talwalkar J; Reddy KR; Watkins PB; Navarro V; Barnhart H; Gu J; Serrano J;
    Gastroenterology; 2015 Jun; 148(7):1340-52.e7. PubMed ID: 25754159
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Idiosyncratic drug-induced liver injury is associated with substantial morbidity and mortality within 6 months from onset.
    Fontana RJ; Hayashi PH; Gu J; Reddy KR; Barnhart H; Watkins PB; Serrano J; Lee WM; Chalasani N; Stolz A; Davern T; Talwakar JA;
    Gastroenterology; 2014 Jul; 147(1):96-108.e4. PubMed ID: 24681128
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comprehensive analysis and insights gained from long-term experience of the Spanish DILI Registry.
    Stephens C; Robles-Diaz M; Medina-Caliz I; Garcia-Cortes M; Ortega-Alonso A; Sanabria-Cabrera J; Gonzalez-Jimenez A; Alvarez-Alvarez I; Slim M; Jimenez-Perez M; Gonzalez-Grande R; Fernández MC; Casado M; Soriano G; Román E; Hallal H; Romero-Gomez M; Castiella A; Conde I; Prieto M; Moreno-Planas JM; Giraldez A; Moreno-Sanfiel JM; Kaplowitz N; Lucena MI; Andrade RJ;
    J Hepatol; 2021 Jul; 75(1):86-97. PubMed ID: 33539847
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Drug Induced Liver Injury at a Tertiary Hospital in India: Etiology, Clinical Features and Predictors of Mortality.
    Rathi C; Pipaliya N; Patel R; Ingle M; Phadke A; Sawant P
    Ann Hepatol; 2017; 16(3):442-450. PubMed ID: 28425415
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Risk of Acute Liver Failure in Patients With Drug-Induced Liver Injury: Evaluation of Hy's Law and a New Prognostic Model.
    Lo Re V; Haynes K; Forde KA; Goldberg DS; Lewis JD; Carbonari DM; Leidl KB; Reddy KR; Nezamzadeh MS; Roy J; Sha D; Marks AR; De Boer J; Schneider JL; Strom BL; Corley DA
    Clin Gastroenterol Hepatol; 2015 Dec; 13(13):2360-8. PubMed ID: 26122767
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Model for end-stage liver disease score as a predictor of short-term outcome in patients with drug-induced liver injury.
    Jeong R; Lee YS; Sohn C; Jeon J; Ahn S; Lim KS
    Scand J Gastroenterol; 2015 Apr; 50(4):439-46. PubMed ID: 25639449
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Profiles of miRNAs in serum in severe acute drug induced liver injury and their prognostic significance.
    Russo MW; Steuerwald N; Norton HJ; Anderson WE; Foureau D; Chalasani N; Fontana RJ; Watkins PB; Serrano J; Bonkovsky HL
    Liver Int; 2017 May; 37(5):757-764. PubMed ID: 27860186
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The Indian Network of Drug-Induced Liver Injury: Etiology, Clinical Features, Outcome and Prognostic Markers in 1288 Patients.
    Devarbhavi H; Joseph T; Sunil Kumar N; Rathi C; Thomas V; Prasad Singh S; Sawant P; Goel A; Eapen CE; Rai P; Arora A; Leelakrishnan V; Gopalakrishnan G; Vardhan Reddy V; Singh R; Goswami B; Venkataraman J; Balaraju G; Patil M; Patel R; Taneja S; Koshy A; Nagaraja Rao P; Kumar Sarin S; Rathi P; Dhiman R; Duseja AK; Vargese J; Kumar Jain A; Wadhawan M; Ranjan P; Karanth D; Ganesh P; Nijhawan S; Krishna Dhali G; Adarsh CK; Jhaveri A; Nagral A; Rao P; Shalimar
    J Clin Exp Hepatol; 2021; 11(3):288-298. PubMed ID: 33994711
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Development and validation of a novel model to predict liver-related mortality in patients with idiosyncratic drug-induced liver injury.
    Wang Y; Zou CL; Zhang J; Qiu LX; Huang YF; Zhao XY; Zou ZS; Jia JD
    Hepatobiliary Pancreat Dis Int; 2023 Dec; 22(6):584-593. PubMed ID: 37308361
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Development and validation of a comorbidity scoring system for patients with cirrhosis.
    Jepsen P; Vilstrup H; Lash TL
    Gastroenterology; 2014 Jan; 146(1):147-56; quiz e15-6. PubMed ID: 24055278
    [TBL] [Abstract][Full Text] [Related]  

  • 13. ACG Clinical Guideline: Diagnosis and Management of Idiosyncratic Drug-Induced Liver Injury.
    Chalasani NP; Maddur H; Russo MW; Wong RJ; Reddy KR;
    Am J Gastroenterol; 2021 May; 116(5):878-898. PubMed ID: 33929376
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Heavy Consumption of Alcohol is Not Associated With Worse Outcomes in Patients With Idiosyncratic Drug-induced Liver Injury Compared to Non-Drinkers.
    Dakhoul L; Ghabril M; Gu J; Navarro V; Chalasani N; Serrano J;
    Clin Gastroenterol Hepatol; 2018 May; 16(5):722-729.e2. PubMed ID: 29306044
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Development and validation of the mortality risk for trauma comorbidity index.
    Thompson HJ; Rivara FP; Nathens A; Wang J; Jurkovich GJ; Mackenzie EJ
    Ann Surg; 2010 Aug; 252(2):370-5. PubMed ID: 20622665
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The Incidence of Drug- and Herbal and Dietary Supplement-Induced Liver Injury: Preliminary Findings from Gastroenterologist-Based Surveillance in the Population of the State of Delaware.
    Vega M; Verma M; Beswick D; Bey S; Hossack J; Merriman N; Shah A; Navarro V;
    Drug Saf; 2017 Sep; 40(9):783-787. PubMed ID: 28555362
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Single-center experience with drug-induced liver injury from India: causes, outcome, prognosis, and predictors of mortality.
    Devarbhavi H; Dierkhising R; Kremers WK; Sandeep MS; Karanth D; Adarsh CK
    Am J Gastroenterol; 2010 Nov; 105(11):2396-404. PubMed ID: 20648003
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Outcome and determinants of mortality in 269 patients with combination anti-tuberculosis drug-induced liver injury.
    Devarbhavi H; Singh R; Patil M; Sheth K; Adarsh CK; Balaraju G
    J Gastroenterol Hepatol; 2013 Jan; 28(1):161-7. PubMed ID: 23020522
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of the sequential organ failure assessment score with the King's College Hospital criteria and the model for end-stage liver disease score for the prognosis of acetaminophen-induced acute liver failure.
    Cholongitas E; Theocharidou E; Vasianopoulou P; Betrosian A; Shaw S; Patch D; O'Beirne J; Agarwal B; Burroughs AK
    Liver Transpl; 2012 Apr; 18(4):405-12. PubMed ID: 22213443
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Validation of the Charlson Comorbidity Index in acutely hospitalized elderly adults: a prospective cohort study.
    Frenkel WJ; Jongerius EJ; Mandjes-van Uitert MJ; van Munster BC; de Rooij SE
    J Am Geriatr Soc; 2014 Feb; 62(2):342-6. PubMed ID: 24521366
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.